Cystatin C and aging success
- PMID: 18227360
- PMCID: PMC2871318
- DOI: 10.1001/archinternmed.2007.40
Cystatin C and aging success
Abstract
Background: To our knowledge, the effect of kidney function on successful aging has not been examined.
Methods: We evaluated the relationship between cystatin C and aging success during a 6-year follow-up in the Cardiovascular Health Study, a community-based cohort of older adults (aged >or= 65 years). Successful aging was defined as remaining free of cardiovascular disease, cancer, and chronic obstructive pulmonary disease and having intact physical and cognitive functioning. In adjusted analysis, an accelerated failure time model was used to evaluate the percentage reduction in successful years by level of cystatin C. A separate Cox proportional hazards model evaluated whether cystatin C was related to incident physical and cognitive disability.
Results: A total of 2140 participants had cystatin C measured and were free of the previously mentioned conditions at baseline. Their mean age was 74 years. The mean cystatin C level, creatinine level, and estimated glomerular filtration rate were 1.06 mg/L, 0.93 mg/dL, and 78 mL/min/1.73 m(2), respectively (to convert cystatin C to nanomoles per liter, multiply by 75; and to convert creatinine to micromoles per liter, multiply by 88.4). A total of 873 participants reached a first event in follow-up, 138 because of cognitive disability, 238 because of physical disability, 34 because of chronic obstructive pulmonary disease, 146 because of cancer, and 317 because of cardiovascular disease. The adjusted percentage reduction in successful life years in the highest vs the lowest quartile of cystatin C was 27% (95% confidence interval, 11%-39%). The highest vs lowest quartile of cystatin C also was independently associated with incident cognitive or physical disability (hazard ratio, 1.39; 95% confidence interval, 1.00-1.98).
Conclusion: A higher cystatin C level, even within a range of relatively normal kidney function, was associated with unsuccessful aging.
Figures
Comment in
-
Successful aging: is it in our future?Arch Intern Med. 2008 Jan 28;168(2):131-2. doi: 10.1001/archinternmed.2007.11. Arch Intern Med. 2008. PMID: 18227356 No abstract available.
Similar articles
-
Cystatin C and prognosis for cardiovascular and kidney outcomes in elderly persons without chronic kidney disease.Ann Intern Med. 2006 Aug 15;145(4):237-46. doi: 10.7326/0003-4819-145-4-200608150-00003. Ann Intern Med. 2006. PMID: 16908914
-
Kidney dysfunction and fatal cardiovascular disease--an association independent of atherosclerotic events: results from the Health, Aging, and Body Composition (Health ABC) study.Am Heart J. 2008 Jan;155(1):62-8. doi: 10.1016/j.ahj.2007.08.012. Epub 2007 Oct 24. Am Heart J. 2008. PMID: 18082491
-
Kidney function and markers of inflammation in elderly persons without chronic kidney disease: the health, aging, and body composition study.Kidney Int. 2007 Feb;71(3):239-44. doi: 10.1038/sj.ki.5002042. Epub 2006 Dec 20. Kidney Int. 2007. PMID: 17183246
-
Cystatin C concentration as a risk factor for heart failure in older adults.Ann Intern Med. 2005 Apr 5;142(7):497-505. doi: 10.7326/0003-4819-142-7-200504050-00008. Ann Intern Med. 2005. PMID: 15809461
-
Cystatin C level as a marker of kidney function in human immunodeficiency virus infection: the FRAM study.Arch Intern Med. 2007 Nov 12;167(20):2213-9. doi: 10.1001/archinte.167.20.2213. Arch Intern Med. 2007. PMID: 17998494 Free PMC article.
Cited by
-
A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup.Geroscience. 2018 Dec;40(5-6):419-436. doi: 10.1007/s11357-018-0042-y. Epub 2018 Aug 27. Geroscience. 2018. PMID: 30151729 Free PMC article. Review.
-
Serial circulating omega 3 polyunsaturated fatty acids and healthy ageing among older adults in the Cardiovascular Health Study: prospective cohort study.BMJ. 2018 Oct 17;363:k4067. doi: 10.1136/bmj.k4067. BMJ. 2018. PMID: 30333104 Free PMC article.
-
Perceptions, Barriers, and Experiences With Successful Aging Before and After Kidney Transplantation: A Focus Group Study.Transplantation. 2020 Mar;104(3):603-612. doi: 10.1097/TP.0000000000002848. Transplantation. 2020. PMID: 31283666 Free PMC article.
-
Cystatin C and Objectively Measured Mobility 10 Years Later in Older Women.J Gerontol A Biol Sci Med Sci. 2016 Nov;71(11):1472-1475. doi: 10.1093/gerona/glw037. Epub 2016 Mar 9. J Gerontol A Biol Sci Med Sci. 2016. PMID: 26961582 Free PMC article.
-
Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies.Kidney Int. 2011 Jan;79(1):14-22. doi: 10.1038/ki.2010.336. Epub 2010 Sep 22. Kidney Int. 2011. PMID: 20861818 Free PMC article. Review.
References
-
- Newman AB, Arnold AM, Naydeck BL, et al. Cardiovascular Health Study Research Group. “Successful aging”: effect of subclinical cardiovascular disease. Arch Intern Med. 2003;163(19):2315–2322. - PubMed
-
- Burke GL, Arnold AM, Bild DE, et al. CHS Collaborative Research Group. Factors associated with healthy aging: the Cardiovascular Health Study. J Am Geriatr Soc. 2001;49(3):254–262. - PubMed
-
- Rowe JW, Kahn RL. Human aging: usual and successful. Science. 1987;237(4811):143–149. - PubMed
-
- Rowe JW, Andres R, Tobin JD, Norris AH, Shock NW. The effect of age on creatinine clearance in men: a cross-sectional and longitudinal study. J Gerontol. 1976;31(2):155–163. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous